Equity (Tables)

3 Months Ended

Jun. 30, 2026

The Company has shares of common stock reserved for issuance as follows (in thousands):


			June 30, 2026
Common stock warrants			172
2010 Plan
Options outstanding			7,442
2021 Plan
Awards outstanding			7,742
Shares available for future grant			40,045
2021 ESPP			12,500
Options outstanding outside the Plans			2,568
Total			70,469

Stock option activities within the Plans as well as outside of the Plans were as follows:


	Number of Shares (in thousands)	Weighted-Average Exercise Price		Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Balance, March 31, 2026	10,464	$	5.06	3.97	$	190,827
Options exercised	(440)	6.38
Options forfeited or expired	(14)	5.75
Balance, June 30, 2026	10,010	5.00		3.70	157,521
Vested and exercisable as of June 30, 2026	8,983	4.65		3.59	144,577
Vested and expected to vest as of June 30, 2026	10,010	5.00		3.70	157,521

The following table summarizes RSU activity (in thousands, except per share information):


	Number of Shares	Weighted- Average Grant Date Fair Value
Unvested balance, March 31, 2026	3,341	$	42.65
Granted	2,889	19.22
Vested	(691)	35.03
Forfeited	(102)	47.56
Unvested balance, June 30, 2026	5,437	31.07

The following table summarizes PSU activity (in thousands, except per share information):


	Number of Shares	Weighted- Average Grant Date Fair Value
Unvested balance, March 31, 2026	2,584	$	36.24
Granted	551	18.97
Vested	(463)	32.40
Forfeited	(367)	46.03
Unvested balance, June 30, 2026	2,305	31.09

Total stock-based compensation expense recognized in the condensed consolidated statements of operations was as follows (in thousands):


	Three Months Ended June 30,
	2026		2025
Cost of revenue	$	3,192	$	2,980
Research and development	15,559		6,649
Sales and marketing	12,425		7,710
General and administrative	5,576		4,526

Total stock-based compensation expense	$	36,752	$	21,865